Modular therapies engineered for immune activation

We build best-in-class immunotherapies for cancer patients by testing millions of candidates to find the best therapies.

Build with us

Today, immunotherapies require trade offs between speed, cost, and quality

It's difficult to predict clinical efficacy today. Development is done at low throughput at great expense, while patients wait. Most developers focus on protein binding, not immune response.

HIGH THROUGHPUT LAB

Screening and testing millions of candidates directly in cells